Prescribing overview
This entry covers single-ingredient Claritin, not decongestant combinations.
Key prescribing checks
- The human label calls for professional assessment with liver or kidney disease.
- Review the entire active-ingredient panel before recommending an over-the-counter product for an animal; the human directions do not supply a veterinary regimen.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Veterinary patients
Not established by reviewed human labelAllergy symptom treatment in animals is not established by the human Drug Facts label.
Animal use requires a veterinarian's separate diagnosis and prescription.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Blocks histamine H1-mediated symptoms.
Absorption, distribution, metabolism and elimination
Veterinary absorption, metabolism and elimination are not established by the reviewed OTC label.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Claritin
Human single-ingredient oral tablet
Contraindications · when not to use
- Drug Facts prohibits use after an allergic reaction to the product or its ingredients.
Precautions & monitoring
- Professional review is needed for liver or kidney disease and pregnancy or breastfeeding.
Human label; this does not establish veterinary approval or an animal treatment protocol.
Combination decongestant products are outside this scope.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Excess use may produce drowsiness; allergic reactions require urgent attention.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
A veterinary dose was not verified from an approved animal label; human dosing is not an animal regimen.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
A product-specific interaction summary has not been established here. An empty list must not be interpreted as “no interactions.” Review the full source and a species-appropriate clinical reference.
Monitoring
Review kidney/liver disease and the complete ingredient list.
Client counseling
Never substitute combination cold/allergy products; contact the veterinarian after accidental overdose.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Store at 20–25°C; secure from children and animals.
Brands, formulations & ingredient identity
Active ingredients
Loratadine
Claritin is loratadine; cetirizine and chlorpheniramine are different drugs, even though all are antihistamines.
Only the single-ingredient product is represented. Do not treat combination cold, allergy or decongestant products as interchangeable.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Claritin
- Formulation
- Single-ingredient oral tablet
- Label / product scope
- Human product
Human OTC label; veterinary use requires a patient-specific decision.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →